Table 2 Fraction of cases positive for urine PCA3 at cutoffs >25 and >35, by total tumor linear dimension (cm) and total PCA3+ tumor linear dimension (cm)
| Â | Summed linear tumor dimension (cm) | Summed PCA3+linear tumor dimension (cm) | ||||||
|---|---|---|---|---|---|---|---|---|
|  | 0–1 | 1.1–2.5 | 2.6–3.5 | >3.5 | 0–1 | 1.1–2.5 | 2.6–3.5 | >3.5 |
Urine PCA3 score>35 | 0/4 (0%) | 8/16 (50%) | 6/8 (75%) | 8/13 (62%) | 6/13 (46%) | 11/18 (61%) | 3/6 (50%) | 4/4 (100%) |
Urine PCA3 score>25 | 2/4 (50%) | 11/16 (69%) | 8/8 (100%) | 8/13 (62%) | 9/13 (69%) | 12/18 (67%) | 4/6 (67%) | 4/4 (100%) |
Urine PCA3 score<25 | 2/4 (50%) | 5/16 (31%) | 0/8 (0%) | 5/13 (38%) | 4/13 (31%) | 6/18 (33%) | 2/6 (33%) | 0/4 (0%) |
